Quick Takeaways
- Capital Research Global Investors filed SCHEDULE 13G for IDEAYA Biosciences, Inc. Common Stock (IDYA).
- Disclosed ownership: 7.5%.
- Date of event: 30 Jun 2025.
Capital Research Global Investors - 30 Jun 2025 SCHEDULE 13G Report for IDEAYA Biosciences, Inc. Common Stock (IDYA)
- Filing Manager
- Capital Research Global Investors
- Reporting Manager
- Capital Research Global Investors
- Symbol
- IDYA
- Shares outstanding
- 87,369,213 shares
- Disclosed Ownership
- 6,552,691 shares
- Ownership
- 7.5%
- Form type
- SCHEDULE 13G
- Filing time
- 13 Aug 2025, 11:37:27 UTC
- Date of event
- 30 Jun 2025
- Next filing
- 12 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Capital Research Global Investors disclosed 7.5% ownership in IDEAYA Biosciences, Inc. Common Stock (IDYA) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Aug 2025, 11:37.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Capital Research Global Investors | 7.5% | 6,552,691 | 6,552,691 | 0 | Jae Won Chung | Vice President and Senior Counsel II, Capital Research and Management Company |